216 related articles for article (PubMed ID: 14645204)
1. Characterization of ARC, apoptosis repressor interacting with CARD, in normal and dystrophin-deficient skeletal muscle.
Abmayr S; Crawford RW; Chamberlain JS
Hum Mol Genet; 2004 Jan; 13(2):213-21. PubMed ID: 14645204
[TBL] [Abstract][Full Text] [Related]
2. Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy.
Porter JD; Merriam AP; Leahy P; Gong B; Feuerman J; Cheng G; Khanna S
Hum Mol Genet; 2004 Feb; 13(3):257-69. PubMed ID: 14681298
[TBL] [Abstract][Full Text] [Related]
3. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
Tidball JG; Wehling-Henricks M
Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
[TBL] [Abstract][Full Text] [Related]
4. IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death.
Smith J; Goldsmith C; Ward A; LeDieu R
Cell Death Differ; 2000 Nov; 7(11):1109-18. PubMed ID: 11139285
[TBL] [Abstract][Full Text] [Related]
5. Targeted inhibition of Ca2+ /calmodulin signaling exacerbates the dystrophic phenotype in mdx mouse muscle.
Chakkalakal JV; Michel SA; Chin ER; Michel RN; Jasmin BJ
Hum Mol Genet; 2006 May; 15(9):1423-35. PubMed ID: 16551657
[TBL] [Abstract][Full Text] [Related]
6. Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy.
Guo C; Willem M; Werner A; Raivich G; Emerson M; Neyses L; Mayer U
Hum Mol Genet; 2006 Mar; 15(6):989-98. PubMed ID: 16476707
[TBL] [Abstract][Full Text] [Related]
7. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
Montgomery E; Pennington C; Isales CM; Hamrick MW
Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S
Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice.
Chakkalakal JV; Harrison MA; Carbonetto S; Chin E; Michel RN; Jasmin BJ
Hum Mol Genet; 2004 Feb; 13(4):379-88. PubMed ID: 14681302
[TBL] [Abstract][Full Text] [Related]
10. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.
Yuasa K; Nakamura A; Hijikata T; Takeda S
BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116
[TBL] [Abstract][Full Text] [Related]
11. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin.
Rooney JE; Welser JV; Dechert MA; Flintoff-Dye NL; Kaufman SJ; Burkin DJ
J Cell Sci; 2006 Jun; 119(Pt 11):2185-95. PubMed ID: 16684813
[TBL] [Abstract][Full Text] [Related]
12. Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice.
Hnia K; Hugon G; Rivier F; Masmoudi A; Mercier J; Mornet D
Am J Pathol; 2007 Feb; 170(2):633-43. PubMed ID: 17255331
[TBL] [Abstract][Full Text] [Related]
13. Downstream utrophin enhancer is required for expression of utrophin in skeletal muscle.
Tanihata J; Suzuki N; Miyagoe-Suzuki Y; Imaizumi K; Takeda S
J Gene Med; 2008 Jun; 10(6):702-13. PubMed ID: 18338831
[TBL] [Abstract][Full Text] [Related]
14. Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness.
Marques MJ; Ventura Machado R; Minatel E; Santo Neto H
Muscle Nerve; 2008 Jan; 37(1):61-7. PubMed ID: 17724738
[TBL] [Abstract][Full Text] [Related]
15. Improvement of calcium handling and changes in calcium-release properties after mini- or full-length dystrophin forced expression in cultured skeletal myotubes.
Marchand E; Constantin B; Balghi H; Claudepierre MC; Cantereau A; Magaud C; Mouzou A; Raymond G; Braun S; Cognard C
Exp Cell Res; 2004 Jul; 297(2):363-79. PubMed ID: 15212940
[TBL] [Abstract][Full Text] [Related]
16. Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle.
Spencer MJ; Montecino-Rodriguez E; Dorshkind K; Tidball JG
Clin Immunol; 2001 Feb; 98(2):235-43. PubMed ID: 11161980
[TBL] [Abstract][Full Text] [Related]
17. The mouse dystrophin muscle promoter/enhancer drives expression of mini-dystrophin in transgenic mdx mice and rescues the dystrophy in these mice.
Anderson CL; De Repentigny Y; Cifelli C; Marshall P; Renaud JM; Worton RG; Kothary R
Mol Ther; 2006 Nov; 14(5):724-34. PubMed ID: 16807118
[TBL] [Abstract][Full Text] [Related]
18. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS
Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609
[TBL] [Abstract][Full Text] [Related]
19. Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity.
Spencer MJ; Walsh CM; Dorshkind KA; Rodriguez EM; Tidball JG
J Clin Invest; 1997 Jun; 99(11):2745-51. PubMed ID: 9169505
[TBL] [Abstract][Full Text] [Related]
20. Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex.
Judge LM; Haraguchiln M; Chamberlain JS
J Cell Sci; 2006 Apr; 119(Pt 8):1537-46. PubMed ID: 16569668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]